Katya Mokretar
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy.
Journal: Irish journal of medical science
Published: June 10, 2024
Recommendations from the AML molecular MRD expert advisory board.
Journal: Leukemia
Published: February 21, 2024
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Journal: Blood advances
Published: June 30, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Journal: Leukemia
Published: May 30, 2023
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.
Journal: Cancers
Published: August 30, 2021
Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's Disease.
Journal: Frontiers in neurology
Published: June 07, 2020
Molecular Monitoring of Chronic Myeloid Leukemia.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 04, 2019
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
Journal: Molecular genetics & genomic medicine
Published: June 19, 2018
Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Journal: Brain : a journal of neurology
Published: October 30, 2017
DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.
Journal: PloS one
Published: February 04, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026